Home > Financial Ratios > GENPHARMASEC

GENPHARMASEC
Working Capital/Sales

    Back to All Ratios
GENPHARMASEC is part of below Screeners ↓
Top Undervalued Small Cap Stocks
COMMUNITY POLL
for GENPHARMASEC
Please provide your vote to see the results

GENPHARMASEC Last 5 Year Working Capital/Sales History

[Standalone]

Mar2023Mar2022Mar2021Mar2020Mar2019
   Working Capital/Sales(x) 1.511.791.091.620.05

What is the latest Working Capital/Sales ratio of GENPHARMASEC ?

The latest Working Capital/Sales ratio of GENPHARMASEC is 1.51 based on Mar2023 Standalone results.
Year Working Capital/Sales
Mar20231.51
Mar20221.79
Mar20211.09
Mar20201.62
Mar20190.05

How is Working Capital/Sales of GENPHARMASEC Trending?

Years Working Capital/Sales % Change
Mar2023 1.51
-15.64
Mar2022 1.79
64.22
Mar2021 1.09
-32.72
Mar2020 1.62
3,140.00
Mar2019 0.05 -

Other Financial Ratios of GENPHARMASEC


Compare Working Capital/Sales ratio of peers of GENPHARMASEC

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GENPHARMASEC ₹122.4 Cr -3.5% 4.3% 16.2% Stock Analytics
SUDARSHAN CHEMICAL INDUSTRIES ₹4,920.7 Cr -0.9% 16.7% 79.6% Stock Analytics
VIDHI SPECIALTY FOOD INGREDIENTS ₹2,317.5 Cr -0.4% -0.7% 20% Stock Analytics
KIRI INDUSTRIES ₹1,912.4 Cr -2.4% 16.2% 26.8% Stock Analytics
BODAL CHEMICALS ₹993.1 Cr -1.3% 2.6% 16.9% Stock Analytics
BHAGERIA INDUSTRIES ₹779.5 Cr -1.8% 20.5% 36.6% Stock Analytics


GENPHARMASEC Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
GENPHARMASEC

-3.5%

4.3%

16.2%

SENSEX

1.4%

2.5%

24.3%


You may also like the below Video Courses